NLRP3 and myocardial ischemia: Taken together, accumulating evidence from recent clinical studies suggests that the detection of the NLRP3 inflammasome and relevant pyroptosis proteins could offer valuable insights for clinical prognosis and be considered a potential therapeutic target for patients with IHD.